Budd-chiari syndrome following Covid-19 infection: a case report
Seri S. Sawaqed, Heba M. Urabi, Mohammad H. Al-thnaibat, Anas Bani-Hani, Omar B. Mohd, Ahmed B. Mohd, Reem A. Ghannam, Hanan Hasan, Yasmeen J. Alabdallat, Abdulrhman Khaity- General Medicine
- Surgery
Introduction and Importance:
Budd-Chiari Syndrome (BCS) is a rare disorder that affects the liver and is caused by blockage of the hepatic veins. Covid-19 has been linked to an increased risk of developing BCS due to its ability to cause inflammation in the body which can lead to clotting disorders
Case Presentation:
A 43-year-old female presented to the emergency department (ER) complaining of severe epigastric and right upper quadrant (RUQ) pain and progressive abdominal distention. Upon the examination, investigation, and triphasic liver computed tomography (CT) with contrast, the patient diagnosed with BCS.
Clinical Discussion:
The patient was started on anticoagulant therapy with low molecular weight heparin (LMWH) and supportive treatment. She was hospitalized for three weeks and discharged on oral warfarin 5 mg/day after showing clinical improvement.
Conclusion:
Hepato-splenomegaly and abdominal distention after COVID-19 infection raise suspicion for BCS. Therefore, early detection of these signs is essential for immediate management.